EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

ETV5 reduces androgen receptor expression and induces neural stem–like properties during neuroendocrine prostate cancer development

Jongeun Lee iD, Jiho Park, Yunjung Hur iD, Dahun Um, Hyung-Seok Choi iD, Joonyoung Park iD, Yewon Kim iD, Jeon-Soo Lee, Kyuha Choi iD, Eunjeong Kim, Young Bin Park iD, Jae-Mun Choi und 2 weitere

Proceedings of the National Academy of Sciences · 2025

DOI: 10.1073/pnas.2420313122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Jongeun Lee und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences, Pohang University of Science and Technology, Pohang, Gyeongbuk 37673, Republic of Korea. Hauptthemen laut MEDLINE: Transcription Factors, Receptors, Androgen, DNA-Binding Proteins, Prostatic Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Research Foundation of Korea (NRF), Ministry of Education (교육부).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuroendocrine prostate cancer (NEPC), an aggressive subtype induced by hormone therapy, lacks effective treatments. This study explored the role of E26 transformation-specific variant 5 (ETV5) in NEPC development. Analysis of multiple prostate cancer datasets revealed that NEPC is characterized by significantly elevated ETV5 expression compared to other subtypes. ETV5 expression increased progressively under hormone therapy through epigenetic modifications. ETV5 induced neural stem–like features in prostate cancer cells and facilitated their differentiation into NEPC under hormone treatment conditions, both in vitro and in vivo. Our molecular mechanistic study identified PBX3 and TLL1 as target genes of ETV5 that contribute to ETV5 overexpression–induced castration resistance and stemness. Notably, obeticholic acid, identified as an ETV5 inhibitor in this study, exhibited promising efficacy in suppressing NEPC development. This study highlights ETV5 as a key transcription factor that facilitates NEPC development and underscores its potential as a therapeutic target for this aggressive cancer subtype.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcription FactorsReceptors, AndrogenDNA-Binding ProteinsProstatic NeoplasmsNeural Stem CellsCarcinoma, NeuroendocrineNeuroendocrine TumorsMaleHumansAnimalsGene Expression Regulation, NeoplasticMiceCell Line, Tumor

Stichwörter der Autor:innen

ETV5androgen receptorcastration resistanceneuroendocrine prostate cancerobeticholic acid

Substanzen

Transcription FactorsReceptors, AndrogenDNA-Binding ProteinsETV5 protein, humanAR protein, human

Autor:innen und Institutionen

  • Department of Life Sciences, Pohang University of Science and Technology, Pohang, Gyeongbuk 37673, Republic of Korea.
  • Department of Biology, College of Natural Sciences, Kyungpook National University, Daegu 41566, Republic of Korea.
  • Calici Co., Ltd., Korea, Daejeon 34134, Republic of Korea.
  • Department of Bio-Artificial Intelligence Convergence, Chungnam National University, Daejeon 34134, Republic of Korea.
  • Department of Food and Biotechnology, Korea University, Sejong 30019, Republic of Korea.
  • Institute for Convergence Research and Education in Advanced Technology, Yonsei University, Seoul 03722, Republic of Korea.

ORCID-Profile: Jongeun Lee, Yunjung Hur, Hyung-Seok Choi, Joonyoung Park, Yewon Kim, Kyuha Choi, Young Bin Park, Yoontae Lee

Förderung

  • National Research Foundation of Korea (NRF)
  • Ministry of Education (교육부)

Zitieren

APA

Lee, J., Park, J., Hur, Y., Um, D., Choi, H. S., Park, J., Kim, Y., Lee, J. S., Choi, K., Kim, E., Park, Y. B., Choi, J. M., Kim, T. K., & Lee, Y. (2025). ETV5 reduces androgen receptor expression and induces neural stem–like properties during neuroendocrine prostate cancer development. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2420313122

Vancouver

Lee J, Park J, Hur Y, Um D, Choi HS, Park J, et al. ETV5 reduces androgen receptor expression and induces neural stem–like properties during neuroendocrine prostate cancer development. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2420313122

BibTeX
@article{Lee2025,
  author = {Lee, Jongeun and Park, Jiho and Hur, Yunjung and Um, Dahun and Choi, Hyung-Seok and Park, Joonyoung and Kim, Yewon and Lee, Jeon-Soo and Choi, Kyuha and Kim, Eunjeong and Park, Young Bin and Choi, Jae-Mun and Kim, Tae-Kyung and Lee, Yoontae},
  title = {ETV5 reduces androgen receptor expression and induces neural stem–like properties during neuroendocrine prostate cancer development},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2025},
  doi = {10.1073/pnas.2420313122}
}
Kostenlos starten →